Atara Biotherapeutics Inc (NASDAQ:ATRA)
7.34 USD
-0.270 3.548%Sponsored Reports
Previous Close (in USD) | 7.61 |
---|---|
Change | -0.270 3.548% |
52 W H/L (in USD) | 2.535/0.199 |
EBITDA (in USD) | -215.793M |
PE Ratio | -- |
Volume | 92921 |
Diluted Eps TTM | -2.12 |
Total Assets (in USD) | 165.504M |
---|---|
Total Liabilities (in USD) | 264.735M |
Revenue TTM (in USD) | 34.704M |
Cash (in USD) | 25.987M |
Market Cap (in USD) | 75.140 M |
Revenue Per Share TTM | 0.302 |
Gross Profit TTM (in USD) | 63.573M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Atara Biotherapeutics Inc
2380 Conejo Spectrum Street, Thousand Oaks, CA, United States, 91320
805 623 4211
Employees: 173
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Dr. Pascal Touchon D.V.M. | Pres, CEO & Director | 1963 |
2. | Mr. Utpal Koppikar M.B.A. | Exec. VP & CFO | 1971 |
3. | Mr. K. Amar Murugan | Sr. VP & Gen. Counsel | 1975 |
4. | Dr. Jakob Dupont M.D. | Exec. VP and Global Head of R&D | 1965 |
5. | Ms. Charlene Banard | Chief Technical Officer | 1963 |
6. | Dr. Anhco Nguyen | Chief Scientific Officer | 1973 |
7. | Eric Hyllengren | VP of Investor Relations & Fin. | NA |
8. | Kerry Beth Daly | Head of Corp. Communications | NA |
9. | Ms. Amie Krause | Chief People Officer | NA |
10. | Mr. Joseph Newell | Exec. VP | 1970 |
Peers
Sector: Healthcare
Industry: Biotechnology
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
NVO
Novo Nordisk A/S |
-0.940 0.807% | 116.24 | 41.580 | 31.153 | 2.134 | 32.989 | 2.113 | 4.700 |
NONOF
Novo Nordisk A/S |
0.000 0.000% | 116.2 | 41.060 | 31.250 | 2.078 | 33.111 | 2.113 | 4.700 |
VRTX
Vertex Pharmaceuticals Inc |
-9.265 2.005% | 460 | 29.670 | 24.331 | 10.385 | 5.832 | 9.334 | 20.004 |
REGN
Regeneron Pharmaceuticals Inc |
-24.030 2.310% | 1037.5 | 29.070 | 20.121 | 7.570 | 3.823 | 6.950 | 19.423 |
Income Statement
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Income Before Tax | -276.111M | -228.29M | -340.095M | -306.605M | -290.964M |
Minority Interest | - | - | - | - | - |
Net Income | -276.126M | -228.302M | -340.141M | -306.62M | -290.976M |
Selling General Administrative | 50.908M | 71.553M | 78.801M | 64.402M | 79.584M |
Gross Profit | -0.313M | 49.005M | 20.34M | -9.867M | -8.105M |
Reconciled Depreciation | 4.879M | 5.653M | 9.345M | 8.332M | 7.07M |
Ebit | -269.276M | -280.513M | -340.462M | -309.052M | -295.681M |
Ebitda | -264.447M | -330.75M | -331.117M | -300.72M | -288.611M |
Depreciation And Amortization | 4.829M | -50.237M | 9.345M | 8.332M | 7.07M |
Operating Income | -269.276M | -280.513M | -340.462M | -309.052M | -295.681M |
Other Operating Expenses | 277.849M | 344.086M | 360.802M | 309.052M | 295.681M |
Interest Expense | 5.285M | 1.986M | 9.712M | 10.779M | 11.787M |
Tax Provision | 0.006M | 0.012M | 0.046M | 0.015M | 0.012M |
Interest Income | 4.797M | 1.986M | 0.367M | 2.447M | 4.717M |
Net Interest Income | 0.944M | 1.986M | 0.367M | 2.447M | 4.717M |
Income Tax Expense | 0.015M | 0.012M | 0.046M | 0.015M | 0.012M |
Total Revenue | 8.573M | 63.573M | 20.34M | 3.552M | 0M |
Total Operating Expenses | 268.963M | 344.086M | 360.802M | 309.052M | 295.681M |
Cost Of Revenue | 8.886M | 14.568M | 11.38M | 9.867M | 8.105M |
Total Other Income Expense Net | -6.835M | 52.223M | 0.367M | 2.447M | 4.717M |
Net Income From Continuing Ops | -290.248M | -228.302M | -340.141M | -306.62M | -290.976M |
Net Income Applicable To Common Shares | - | -228.302M | -340.141M | -306.62M | -290.976M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Total Assets | 165.504M | 376.42M | 468.127M | 588.12M | 342.942M |
Intangible Assets | - | - | - | - | - |
Other Current Assets | 6.184M | 10.308M | 12.567M | 21.364M | 13.883M |
Total Liab | 264.735M | 249.78M | 188.513M | 125.781M | 52.161M |
Total Stockholder Equity | -99.231M | 126.64M | 279.614M | 462.339M | 290.781M |
Other Current Liab | 48.53M | 50.405M | 44.905M | 40.343M | 5.733M |
Common Stock | 0.011M | 0.01M | 0.009M | 0.008M | 0.006M |
Capital Stock | 0.011M | 0.01M | 0.009M | 0.008M | 0.006M |
Retained Earnings | -1969.15M | -1693.024M | -1464.722M | -1124.581M | -817.961M |
Good Will | - | - | - | - | - |
Other Assets | 0M | 7.018M | 3.567M | 14.33M | 1.767M |
Cash | 25.987M | 92.942M | 106.084M | 200.404M | 74.317M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 142.226M | 78.916M | 105.786M | 82.901M | 36.743M |
Current Deferred Revenue | 77.833M | 8M | 40.76M | 33.455M | 21.466M |
Net Debt | 31.885M | -21.238M | -80.566M | -187.363M | -60.181M |
Short Term Debt | 12.179M | 13.64M | 2.753M | 1.985M | 1.581M |
Short Long Term Debt | - | - | - | - | - |
Short Long Term Debt Total | 57.872M | 71.704M | 25.518M | 13.041M | 14.136M |
Other Stockholder Equity | 1870.112M | 1821.721M | 1744.695M | 1586.616M | 1108.516M |
Property Plant Equipment | - | 6.3M | 79.939M | 50.517M | 54.176M |
Total Current Assets | 101.869M | 295.08M | 384.621M | 523.273M | 272.992M |
Long Term Investments | - | - | - | - | - |
Short Term Investments | 25.884M | 149.877M | 264.984M | 300.255M | 184.792M |
Net Receivables | 34.108M | 40.221M | 0.986M | 1.25M | - |
Long Term Debt | - | - | - | - | - |
Inventory | 9.706M | 1.586M | - | - | - |
Accounts Payable | 3.684M | 6.871M | 17.368M | 7.118M | 7.963M |
Accumulated Other Comprehensive Income | -0.204M | -2.067M | -0.368M | 0.296M | 0.22M |
Non Currrent Assets Other | 4.844M | 7.018M | 3.567M | 2.027M | 1.767M |
Non Current Assets Total | 63.635M | 81.34M | 83.506M | 64.847M | 69.95M |
Capital Lease Obligations | 57.872M | 71.704M | 25.518M | 15.026M | 15.717M |
Long Term Debt Total | - | - | - | - | 0.244M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Investments | 165.14M | 112.384M | 32.838M | -116.215M | 66.031M |
Total Cashflows From Investing Activities | - | 202.956M | 22.258M | -120.728M | 60.459M |
Total Cash From Financing Activities | 2.01M | 53.084M | 103.944M | 427.574M | 188.786M |
Net Income | -276.126M | -228.302M | -340.141M | -306.62M | -290.976M |
Change In Cash | -67.101M | -14.39M | -94.32M | 126.087M | 13.619M |
Begin Period Cash Flow | 93.088M | 107.478M | 201.798M | 75.711M | 62.092M |
End Period Cash Flow | 25.987M | 93.088M | 107.478M | 201.798M | 75.711M |
Total Cash From Operating Activities | -192.977M | -270.43M | -220.522M | -180.759M | -235.626M |
Depreciation | 4.829M | 5.653M | 9.345M | 8.332M | 7.07M |
Other Cashflows From Investing Activities | - | 94.765M | - | - | 0.161M |
Dividends Paid | - | 0.623M | 1.244M | 1.521M | 6.695M |
Change To Inventory | -8.12M | -1.586M | 3.343M | -1.252M | -1.586M |
Sale Purchase Of Stock | -0.094M | -0.623M | -1.244M | -1.521M | -6.695M |
Other Cashflows From Financing Activities | -0.107M | 2.352M | 7.989M | 8.036M | 14.045M |
Capital Expenditures | 1.223M | 4.193M | 10.58M | 4.513M | 5.733M |
Change In Working Capital | 15.341M | -61.468M | 52.584M | 63.685M | -4.148M |
Other Non Cash Items | 12.456M | -40.151M | 2.035M | 1.535M | 1.035M |
Free Cash Flow | -194.2M | -274.623M | -231.102M | -185.272M | -241.359M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Vanguard Total Stock Mkt Idx Inv | 5 months ago | 2710236 |
2. | iShares Russell 2000 ETF | 5 months ago | 2277427 |
3. | Vanguard Institutional Extnd Mkt Idx Tr | 5 months ago | 1361836 |
4. | Fidelity Small Cap Index | 7 months ago | 974144 |
5. | State St Russell Sm/Mid Cp® Indx NL Cl C | 5 months ago | 957477 |
6. | iShares Russell 2000 Value ETF | 5 months ago | 827460 |
7. | Fidelity Extended Market Index | 6 months ago | 540091 |
8. | JPMorgan US Small Company L | 6 months ago | 495800 |
9. | Schwab US Small-Cap ETF™ | 5 months ago | 486756 |
10. | Vanguard Russell 2000 ETF | 5 months ago | 367954 |
11. | State St Russell Sm Cap® Indx SL Cl I | 5 months ago | 360982 |
12. | Vanguard Health Care ETF | 5 months ago | 275876 |
13. | NT R2000 Index Fund - NL | 6 months ago | 271193 |
14. | NT R2000 Value Index Fund - NL | 9 months ago | 255474 |
15. | Fidelity VIP Disciplined Small Cap Init | 7 months ago | 240778 |
16. | Schwab Small Cap Index | 5 months ago | 235645 |
17. | BlackRock Extended Mkt Composite | 1 year ago | 227436 |
18. | NT R2000 Index Fund - DC - NL - 2 | 6 months ago | 215364 |
19. | iShares Micro-Cap ETF | 5 months ago | 203143 |
20. | BlackRock Extended Equity Market K | 6 months ago | 192955 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | EcoR1 Capital, LLC | 6 months ago | 10167043 |
2. | Redmile Group, LLC | 6 months ago | 9263309 |
3. | BlackRock Inc | 9 months ago | 7087213 |
4. | Vanguard Group Inc | 6 months ago | 5012938 |
5. | T. Rowe Price Associates, Inc. | 6 months ago | 4958150 |
6. | Boxer Capital LLC | 6 months ago | 4150000 |
7. | UBS Group AG | 9 months ago | 3693225 |
8. | Vestal Point Capital LP | 6 months ago | 2800000 |
9. | State Street Corporation | 9 months ago | 2784200 |
10. | Acadian Asset Management LLC | 6 months ago | 2638687 |
11. | AQR Capital Management LLC | 6 months ago | 2625468 |
12. | JPMorgan Chase & Co | 9 months ago | 2188044 |
13. | Geode Capital Management, LLC | 9 months ago | 2150150 |
14. | TANG CAPITAL MANAGEMENT LLC | 6 months ago | 1879923 |
15. | Morgan Stanley - Brokerage Accounts | 9 months ago | 1793371 |
16. | Woodline Partners LP | 6 months ago | 1774802 |
17. | Goldman Sachs Group Inc | 9 months ago | 1164378 |
18. | Staley Capital Advisers Inc | 9 months ago | 1000000 |
19. | J. Goldman & Co LP | 6 months ago | 986651 |
20. | Checkpoint Capital LP | 6 months ago | 892853 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).